Skip to search formSkip to main contentSkip to account menu

cholebine

Known as: colestilan 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Bile Acids and Salts

Narrower (1)

MCI-196

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
BACKGROUND Phosphate binders are used to reduce positive phosphate balance and to lower serum phosphate levels for people with… 
Highly Cited
2016
Highly Cited
2016
Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials.
BACKGROUND Guidelines preferentially recommend noncalcium phosphate binders in adults with chronic kidney disease (CKD). We… 
Review
2014
Review
2014
Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles
Introduction: Hyperphosphatemia is common in the late stages of chronic kidney disease (CKD) and is associated with elevated… 
2013
2013
The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study
Background This study compared the effects of short-term titrated colestilan (a novel non-absorbable, non-calcium, phosphate… 
Review
2013
Review
2013
Use of phosphate binders in chronic kidney disease
Purpose of reviewHyperphosphatemia is a paradigmatic finding in late-stage chronic kidney disease (CKD) and consistently… 
Review
2012
Review
2012
Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus : Focus on Bile Acid Sequestrants.
Type 2 diabetes mellitus is associated with a progressive decline in insulinproducing pancreatic β-cells, an increase in hepatic… 
Review
2011
Review
2011
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.
BACKGROUND Phosphate binders are widely used to lower serum phosphorus levels in people with chronic kidney disease (CKD) but… 
2010
2010
Metal ion and vitamin adsorption profiles of phosphate binder ion-exchange resins.
AIMS To determine the metal ion and vitamin in vitro adsorption profile of sevelamer hydrochloride (sevelamer-HCl) and colestilan… 
2010
2010
Colestilan monotherapy significantly improves glycaemic control and LDL cholesterol levels in patients with type 2 diabetes: a randomized double‐blind placebo‐controlled study
Aim: To evaluate the plasma glucose‐reducing activity and safety of colestilan, a bile acid sequestrant, in patients with type 2… 
2005
2005
Effect of MCI-196 (colestilan) as a phosphate binder on hyperphosphataemia in aemodialysis patients: a double-blind, placebo-controlled, short-term trial.
BACKGROUND MCI-196 (colestilan), an anion exchange resin, is widely used as an anti-hypercholesterolaemic drug in Japan. To… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)